Source link : https://newshealth.biz/health-news/study-on-glp-1s-and-breast-cancer-too-good-to-be-true/
Patients with breast cancer and metabolic comorbidities have increased risks for cancer recurrence and death. This retrospective study suggested that GLP-1 agonist use for diabetes or obesity was associated with lower all-cause mortality and improved recurrence-free survival in breast cancer. However, outside experts raised a series of concerns about the study, including mortality effect sizes […]
The post Study on GLP-1s and Breast Cancer ‘Too Good to Be True’? first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-12 21:43:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8